• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

rs9373441 与 FOXP3+Treg 和 Tr1 对类风湿关节炎中 csDMARDs 临床疗效的功能影响。

Functional implications of rs9373441 with FOXP3+Treg and Tr1 for the clinical effectiveness of csDMARDs in rheumatoid arthritis.

机构信息

School of Medicine, National Defense Medical Center, ROC, Taipei, Taiwan.

School of Public Health, National Defense Medical Center, ROC, Taipei, Taiwan.

出版信息

Clin Chim Acta. 2023 Nov 1;551:117612. doi: 10.1016/j.cca.2023.117612. Epub 2023 Oct 20.

DOI:10.1016/j.cca.2023.117612
PMID:37866653
Abstract

Rheumatoid arthritis (RA) is characterized by a deficiency in regulatory T cells (Treg), which play a crucial role in immune regulation. While conventional synthetic disease-modifying antirheumatic drugs (csDMARDs) are widely used, there remains a challenge as efficacy varies among patients. In this genome-wide association study (GWAS) involving 410 RA patients, rs9373441 emerged as the most significantly linked single-nucleotide polymorphism (SNP) to csDMARDs response. This non-coding variant functions as a cis-acting regulatory element within the UTRN gene, which is associated with cortical erosion and osteoporosis. Particularly, individuals with the TT allele at rs9373441 exhibited a more favorable response, characterized by a significant increase in FOXP3 + Treg and Type 1 regulatory T cells (Tr1) (p = 0.04, 0.02) and a decrease in Effector T helper cells (Effector Th) (p = 0.03). The GATA3-GCM2-PTH and GATA3-FOXO1-FOXP3 pathways were implicated. RNA-sequencing (RNA-seq) analysis revealed increased expression levels of UTRN, PTH2R, FOXO1, and FOXO3 in good and moderate responders (p = 0.01, 0.03, 0.0005, and 0.02). Notably, the change in FOXP3 + Treg and Tr1 was positively correlated with UTRN expression (both p = 0.03). These findings underscore the critical link between rs9373441 and the response to csDMARDs, empowering clinicians to tailor treatments for enhanced outcomes in patients with RA.

摘要

类风湿关节炎(RA)的特征是调节性 T 细胞(Treg)缺乏,而 Treg 在免疫调节中起着至关重要的作用。虽然广泛使用传统的合成疾病修饰抗风湿药物(csDMARDs),但由于患者之间的疗效存在差异,仍然存在挑战。在这项涉及 410 名 RA 患者的全基因组关联研究(GWAS)中,rs9373441 是与 csDMARDs 反应最显著相关的单核苷酸多态性(SNP)。这种非编码变体作为 UTRN 基因内的顺式作用调节元件发挥作用,与皮质侵蚀和骨质疏松症有关。特别是,rs9373441 处的 TT 等位基因个体表现出更有利的反应,其特征是 FOXP3+Treg 和 Type 1 调节性 T 细胞(Tr1)显著增加(p=0.04,0.02),效应 T 辅助细胞(Effector Th)减少(p=0.03)。GATA3-GCM2-PTH 和 GATA3-FOXO1-FOXP3 途径被牵连。RNA 测序(RNA-seq)分析显示,在良好和中度反应者中,UTR N、PTH2R、FOXO1 和 FOXO3 的表达水平增加(p=0.01,0.03,0.0005 和 0.02)。值得注意的是,FOXP3+Treg 和 Tr1 的变化与 UTRN 表达呈正相关(均 p=0.03)。这些发现强调了 rs9373441 与 csDMARDs 反应之间的关键联系,使临床医生能够为 RA 患者量身定制治疗方案,以提高治疗效果。

相似文献

1
Functional implications of rs9373441 with FOXP3+Treg and Tr1 for the clinical effectiveness of csDMARDs in rheumatoid arthritis.rs9373441 与 FOXP3+Treg 和 Tr1 对类风湿关节炎中 csDMARDs 临床疗效的功能影响。
Clin Chim Acta. 2023 Nov 1;551:117612. doi: 10.1016/j.cca.2023.117612. Epub 2023 Oct 20.
2
Using Treg, Tr1, and Breg Expression Levels to Predict Clinical Responses to csDMARD Treatment in Drug-naive Patients With Rheumatoid Arthritis.使用 Treg、Tr1 和 Breg 表达水平预测初治类风湿关节炎患者对 csDMARD 治疗的临床反应。
In Vivo. 2023 Sep-Oct;37(5):2018-2027. doi: 10.21873/invivo.13299.
3
The balance between Foxp3 and Ror-γt expression in peripheral blood is altered by tocilizumab and abatacept in patients with rheumatoid arthritis.类风湿关节炎患者外周血中Foxp3与Ror-γt表达之间的平衡会被托珠单抗和阿巴西普改变。
BMC Musculoskelet Disord. 2016 Jul 16;17:290. doi: 10.1186/s12891-016-1137-1.
4
Circulating PCSK9 relates to aggravated disease activity, Th17/Treg imbalance, and predicts treatment outcome of conventional synthetic DMARDs in rheumatoid arthritis patients.循环 PCSK9 与疾病活动加重、Th17/Treg 失衡有关,并可预测类风湿关节炎患者常规合成 DMARDs 的治疗效果。
Ir J Med Sci. 2023 Dec;192(6):3187-3194. doi: 10.1007/s11845-023-03323-8. Epub 2023 Feb 24.
5
Regulatory T cells in patients with early untreated rheumatoid arthritis: Phenotypic changes in the course of methotrexate treatment.早期未经治疗的类风湿关节炎患者中的调节性 T 细胞:甲氨蝶呤治疗过程中的表型变化。
Biochimie. 2020 Jul;174:9-17. doi: 10.1016/j.biochi.2020.03.014. Epub 2020 Apr 7.
6
Methotrexate Restores Regulatory T Cell Function Through Demethylation of the FoxP3 Upstream Enhancer in Patients With Rheumatoid Arthritis.甲氨蝶呤通过去甲基化类风湿关节炎患者 FoxP3 上游增强子恢复调节性 T 细胞功能。
Arthritis Rheumatol. 2015 May;67(5):1182-92. doi: 10.1002/art.39031.
7
Conventional DMARDs therapy decreases disease activity and inflammation in newly diagnosed patients with rheumatoid arthritis by increasing FoxP3, Sema-3A, and Nrp-1 gene expression.常规的 DMARDs 治疗通过增加 FoxP3、Sema-3A 和 Nrp-1 基因的表达,降低新诊断为类风湿关节炎患者的疾病活动度和炎症。
Inflammopharmacology. 2024 Dec;32(6):3687-3695. doi: 10.1007/s10787-024-01565-1. Epub 2024 Sep 4.
8
Involvement of Tumor Necrosis Factor Receptor Type II in FoxP3 Stability and as a Marker of Treg Cells Specifically Expanded by Anti-Tumor Necrosis Factor Treatments in Rheumatoid Arthritis.肿瘤坏死因子受体 II 型在 FoxP3 稳定性中的作用及其作为类风湿关节炎中抗肿瘤坏死因子治疗特异性扩增的 Treg 细胞的标志物。
Arthritis Rheumatol. 2020 Apr;72(4):576-587. doi: 10.1002/art.41134. Epub 2020 Feb 20.
9
Polymorphism of Foxp3 gene affects the frequency of regulatory T cells and disease activity in patients with rheumatoid arthritis in Iranian population.Foxp3 基因多态性影响伊朗人群类风湿关节炎患者调节性 T 细胞的频率和疾病活动。
Immunol Lett. 2018 Dec;204:16-22. doi: 10.1016/j.imlet.2018.10.001. Epub 2018 Oct 4.
10
Corrigendum to "Functional implications of rs9373441 with FOXP3+Treg and Tr1 for the clinical effectiveness of csDMARDs in rheumatoid arthritis" [Clinica Chimica Acta 551 (2023) 117612].《rs9373441与FOXP3 + Treg及Tr1对类风湿关节炎中传统合成改善病情抗风湿药临床疗效的功能影响》勘误 [《临床化学学报》551 (2023) 117612]
Clin Chim Acta. 2025 Feb 15;568:120146. doi: 10.1016/j.cca.2025.120146. Epub 2025 Jan 24.

引用本文的文献

1
Multi-Omics Analysis Revealed the rSNPs Potentially Involved in T2DM Pathogenic Mechanism and Metformin Response.多组学分析揭示了 rSNP 可能参与 T2DM 发病机制和二甲双胍反应。
Int J Mol Sci. 2024 Aug 27;25(17):9297. doi: 10.3390/ijms25179297.